Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2025-12-24 @ 7:10 PM
NCT ID:
NCT00230503
Eligibility Criteria:
Inclusion Criteria:
* Compensated chronic HBV Infection
* No prior treatment with adefovir dipivoxil
* No interferon or lamivudine treatment for three months prior to enrollment
* HBeAg positive or negative
* HBV DNA viral load greater than 500,000 copies per mL
* ALT between 1.2 and 10 times ULN
Exclusion Criteria:
* Positive HIV, HCV, and/or HDV serology
* History of renal tubular necrosis
* Serum creatinine greater than 2.0 mg/dl
* History of organ transplant or use of immunosuppresive drugs
* Pregnant or breast-feeding females
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00230503
Study Brief:
Protocol Section:
NCT00230503